Article

Medicare physician payment cut still scheduled for July 1 unless Senate action continues

The senate failed to adopt H.R. 6331, late last night after it was agreed to bring up the bill.

Washington, DC-The senate failed to adopt H.R. 6331, late last night after it was agreed to bring up the bill. In a move to be able to call up the bill at a future date, Senate Majority Leader Harry Reid (D-NV) changed his vote to "NO." Sixty votes were needed to pass the bill.

The 10.6% Medicare physician payment cut scheduled to take effect on July 1 could have been delayed for 30 days by legislation offered by Senate Minority Leader Mitch McConnell (R-KY), allowing more time to come to the negotiating table. However, Senator Reid objected to this and if no further action takes place before the Senate adjourns for the July 4 recess, the 10.6% cut will take effect July 1.

All Democrats voted in favor of the bill, with the exception of Senator Reid. Nine Republicans also voted in favor of the measure: Senators Norm Coleman (MN), Susan Collins (ME), Elizabeth Dole (NC), Lisa Murkowski (AK), Pat Roberts (KS), Gordon Smith (OR), Olympia Snowe (ME), Ted Stevens (AK), and George Voinovich (OH).

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.